AutomateNexus Voice Launches AI-Powered Virtual Receptionist to Help Small Businesses Capture Every Lead 
Celestion Brings Cutting-Edge Music Technology to Transform Hong Kong’s Modern Listening Experience 
The FUTR Corporation Appoints Technology Financier G. Scott Paterson to its Board of Directors and as Chairman of the Board Valneva Announces an Indicative Price Range of its Previously Announced Proposed Global Offering
Saint-Herblain (France), May 5, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
Supernus Announces Paragraph IV ANDA Filing for XADAGO®
ROCKVILLE, Md., May 04, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
On track to refile Libervant™ (diazepam) Buccal Film New Drug Application (NDA) by end of…
Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a…
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
First-of-its-kind software predicts likelihood of off-target safety issues that could impede clinical progress PRINCETON, N.J.,…
Lowell Farms Inc. Announces First Quarter 2021 Financial Results
Vertically-integrated cannabis leader finishes quarter with multiple post-merger successes and strong position for future expansion…
Vaccitech Announces Closing of $110.5 Million Initial Public Offering
OXFORD, United Kingdom, May 04, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage…
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform
Transformative, leading allogeneic NKT cell platform technology expands Athenex’s cell therapy development capability Platform has…
Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update
New Drug Application (NDA) submission for topical roflumilast cream as a potential treatment for plaque…
Iovance Biotherapeutics to Present at Upcoming Conferences
SAN CARLOS, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Lixte Biotechnology to Present Key Advantages of Novel Cancer Drug Candidate LB-100 at the Sidoti Virtual Microcap Conference on May 20
Multiple pre-clinical studies indicate that Lixte’s lead clinical drug candidate LB-100 enhances the effectiveness of…
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021
ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021 Conference…
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
Seer to Present at the BofA Securities 2021 Healthcare Conference
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
Ascendis Pharma A/S Announces Participation at the BofA Securities 2021 Virtual Health Care Conference
COPENHAGEN, Denmark, May 04, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention
Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention…
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
DEER PARK, Ill., May 04, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Agile Therapeutics Reports First Quarter 2021 Financial Results
Prescription Growth Reflects Increasing Demand for Twirla Base of Prescribers Continues to Grow in First…
Sana Biotechnology to Present at the BofA Securities 2021 Healthcare Conference
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
Imsidolimab Phase 3 GPP trial anticipated to commence in mid-2021 following FDA end-of-Phase 2 meeting held…